Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

June 2009

06.24.2009
Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors
06.17.2009
Pfizer Invites Public to View and Listen to Webcast of July 22 Conference Call with Analysts
06.17.2009
Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC
06.10.2009
Pfizer’s Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show
06.02.2009
Pfizer Announces Completion Of European Debt Offering
06.02.2009
FDA Approves First Canine Cancer Therapy
06.01.2009
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder
06.01.2009
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer

May 2009

05.30.2009
Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab
05.29.2009
Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer
05.29.2009
New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment
05.29.2009
Pfizer Invites Public to View and Listen to Webcast of June 12 Conference Call with Analysts at EULAR

Page 189
Page 190
Current page 191
Page 192
Page 193

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube